# Clinical Trial of H2-BP Electronic Sphygmomanometer

Study · id `cardio:ct-nct06491433` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06491433](<https://clinicaltrials.gov/study/NCT06491433>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06491433

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 141 participants.

## Technical summary

Registry record NCT06491433. Non-randomized; no masking; primary purpose diagnostic. Start 2023-04-27 (actual); primary completion 2024-10-15 (actual). Results posted on 2025-03-03.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 141 participants (enrolled count; ClinicalTrials.gov record NCT06491433, source copy `cardio:ctgov-nct06491433-2025-03-03`, retrieved 2026-10-26)
- Started: 2023-04-27 (actual) (ClinicalTrials.gov record NCT06491433, source copy `cardio:ctgov-nct06491433-2025-03-03`, retrieved 2026-10-26)
- Primary completion: 2024-10-15 (actual) (ClinicalTrials.gov record NCT06491433, source copy `cardio:ctgov-nct06491433-2025-03-03`, retrieved 2026-10-26)
- Completion: 2024-10-15 (actual) (ClinicalTrials.gov record NCT06491433, source copy `cardio:ctgov-nct06491433-2025-03-03`, retrieved 2026-10-26)
- Results first posted: 2025-03-03 (ClinicalTrials.gov record NCT06491433, source copy `cardio:ctgov-nct06491433-2025-03-03`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT06491433, source copy `cardio:ctgov-nct06491433-2025-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06491433-2025-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial of H2-BP Electronic Sphygmomanometer
- Condition: Low Blood Pressure
- Condition: Normal Blood Pressure
- Condition: Prehypertension
- Condition: Hypertension
- Intervention (Device): H2-BP
- Lead sponsor: Gangnam Severance Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Gangnam Severance Hospital (`cardio:org-gangnam-severance-hospital`)

## Provenance

Content hash: 8dc16795ee32987196e1c54a79ac104cf0e8ec2b2acc4c174fec18f166c80214
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
